NOVARTIS AG-SPONSORED ADR (NVS:NYSE)
$159.85 3.74 (2.3957%)
Analysed NOVARTIS AG-SPONSORED ADR (NVS:NYSE) News Sources
Novartis Is On The Rise. But So, Too, Are Its Generic Rivals.
21-07-2026
yahoo.com
Novartis (NVS) Q2 2026 Earnings Call Transcript
22-07-2026
fool.com
Novartis (SWX:NOVN) Is Pushing AI Deeper Into Drug Discovery
22-07-2026
yahoo.com
Company News for July 22, 2026
22-07-2026
yahoo.com
CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight
22-07-2026
yahoo.com
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
23-07-2026
yahoo.com
Incyte Gears Up to Report Q2 Earnings: Is a Beat Around the Corner?
24-07-2026
yahoo.com
Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
27-07-2026
yahoo.com
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
27-07-2026
yahoo.com
INCY Q2 Earnings & Revenues Beat on Higher Sales, '26 View Raised
28-07-2026
yahoo.com
What is the current price of NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The current price of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is $159.85.
NOVARTIS AG-SPONSORED ADR (NVS:NYSE) absolute price change since previous trading day?
The absolute price change of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) since the previous trading day is $3.74.
NOVARTIS AG-SPONSORED ADR (NVS:NYSE) percentage price change since previous trading day?
The percentage price change of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) since the previous trading day is 2.3957%.
What is the most recent average sentiment score for NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The most recent average sentiment score for NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is 57 out of 100.
What is the most recent average sentiment for NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The most recent sentiment for NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is .
SEC-8K** Filing Available For NOVARTIS AG-SPONSORED ADR (NVS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.